Pivotal bioVenture

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund founded in 2017, primarily investing in private companies in North America and Europe. It focuses on innovative therapeutic products and platforms to address significant unmet medical needs. From company creation to mid-to-late stage clinical development, Pivotal bioVenture Partners invests across all stages of company growth. The team at Pivotal bioVenture Partners brings extensive experience in venture capital, company building, and drug discovery and development, enabling them to collaborate with entrepreneurs to drive business growth.